InsidersTradesSigma
Explore the complete record of transactions filed by BAIK BRIAN SEUNG WON(백승원), Chairman & CEO. Director active across 2 companies, notably 케이엠제약. Aggregated, 4 reports have been logged. The latest transaction was filed on 15 April 2026 — Purchase. Regulator: DART (FSS). The full history is openly available.
4 of 4 declarations
BAIK BRIAN SEUNG WON is the Chairman & CEO of KM Pharmaceutical. He is responsible for the strategic direction of the company and the management of daily operations. With his experience, BAIK BRIAN SEUNG WON plays a key role in strategic decision-making and defining the company's long-term vision.